beta-Lactamases_NNS of_IN Kluyvera_NP ascorbata_NNS ,_, Probable_JJ Progenitors_NNS of_IN Some_DT Plasmid-Encoded_NP CTX-M_NP Types_NP Kluyvera_NP ascorbata_NN produces_VBZ a_DT beta-lactamase_NN that_IN results_NNS in_IN an_DT atypical_JJ susceptibility_NN pattern_NN ,_, including_VBG low-level_JJ resistance_NN to_TO penicillins_NNS ,_, cephalothin_NN ,_, and_CC cefuroxime_NN ,_, but_CC this_DT resistance_NN is_VBZ reversed_VBN by_IN clavulanate_NN ._SENT Ten_CD nucleotide_NN sequences_NNS of_IN the_DT corresponding_JJ gene_NN ,_, blaKLUA_NP ,_, were_VBD obtained_VBN and_CC were_VBD found_VBN to_TO have_VB minor_JJ variations_NNS (_( 96_CD to_TO 100_CD %_NN )_) ._SENT Otherwise_RB ,_, blaKLUA_NN was_VBD found_VBN to_TO be_VB similar_JJ (_( 95_CD to_TO 100_CD %_NN )_) to_TO some_DT plasmid-encoded_JJ CTX-M-type_NP beta-lactamases_NNS ._SENT Finally_RB ,_, mobilization_NN of_IN blaKLUA_NN on_IN a_DT plasmid_NN was_VBD found_VBN to_TO be_VB mediated_VBN probably_RB by_IN a_DT genetic_JJ mobile_JJ element_NN like_IN ISEcp1_NP ._SENT Resistance_NN to_TO oxyimino-beta-lactams_NNS such_JJ as_IN cefotaxime_NN ,_, ceftazidime_NN ,_, or_CC ceftriaxone_NN in_IN gram-negative_JJ rods_NNS has_VBZ commonly_RB been_VBN associated_VBN with_IN the_DT expression_NN of_IN acquired_VBN beta-lactamases_NNS ._SENT Most_JJS of_IN them_PP are_VBP class_NN A_DT extended-spectrum_NN beta-lactamase_NN (_( ESBL_NP )_) derivatives_NNS of_IN the_DT TEM-1_NP ,_, TEM-2_NP ,_, or_CC SHV-1_JJ enzyme_NN ._SENT Since_IN the_DT 1990s_NNS ,_, a_DT new_JJ step_NN in_IN resistance_NN to_TO beta-lactams_NNS was_VBD discovered_VBN with_IN the_DT demonstration_NN of_IN the_DT mobilization_NN of_IN a_DT chromosomal_JJ beta-lactamase_NN on_IN a_DT plasmid_NN ,_, allowing_VBG the_DT wide_JJ dissemination_NN of_IN beta-lactamases_NNS and_CC conferring_VBG the_DT potential_NN for_IN epidemic_JJ problems_NNS ._SENT Many_JJ plasmid-mediated_JJ AmpC_NP beta-lactamases_NNS have_VBP been_VBN described_VBN ,_, such_JJ as_IN MIR-1_NP (_( Enterobacter_NP cloacae_NNS )_) ,_, CMY-2_NP (_( Citrobacter_NP freundii_NP )_) ,_, DHA-1_NP (_( Morganella_NP morganii_NP )_) ,_, and_CC ACC-1_NP (_( Hafnia_NP alvei_NP )_) ._SENT More_RBR recently_RB ,_, the_DT discovery_NN of_IN SFO-1_NP suggested_VBD a_DT probable_JJ mobilization_NN from_IN the_DT chromosome_NN of_IN Serratia_NP fonticola_NP on_IN a_DT plasmid_NN harbored_VBN in_IN an_DT E._NP cloacae_NNS isolate_VBP in_IN Japan_NP ._SENT To_TO date_NN ,_, that_WDT was_VBD the_DT only_JJ report_NN of_IN the_DT mobilization_NN of_IN a_DT chromosomally_RB mediated_VBN class_NN A_DT beta-lactamase_NN ._SENT The_DT CTX-M-type_NP beta-lactamases_NNS (_( CTX-M-1_JJ to_TO CTX-M-15_NP ,_, Toho-1_NP and_CC Toho-2_NP ,_, and_CC UOE-1_NP and_CC UOE-2_NP )_) ,_, encoded_VBN by_IN transferable_JJ plasmids_NNS ,_, constitute_VBP a_DT novel_JJ group_NN of_IN class_NN A_DT ESBLs_NNS whose_WP$ origins_NNS are_VBP still_RB unknown_JJ ._SENT These_DT CTX-M-type_NP enzymes_NNS are_VBP not_RB closely_RB related_VBN to_TO TEM_NP or_CC SHV_NP ESBLs_NP but_CC share_VB extensive_JJ similarities_NNS (_( 70_CD to_TO 75_CD %_NN )_) with_IN the_DT chromosomal_JJ Klebsiella_NP oxytoca_NN beta-lactamases_NNS ._SENT Nevertheless_RB ,_, Kluyvera_NP ascorbata_NNS ,_, a_DT species_NN of_IN the_DT family_NN Enterobacteriaceae_NN that_WDT is_VBZ rarely_RB detected_VBN in_IN medical_JJ practice_NN ,_, was_VBD suggested_VBN as_IN another_DT probable_JJ progenitor_NN because_IN of_IN the_DT particular_JJ susceptibility_NN patterns_NNS of_IN some_DT clinical_JJ isolates_NNS including_VBG resistance_NN to_TO cefotaxime_NN and_CC aztreonam_NN but_CC susceptibility_NN to_TO ceftazidime_NN and_CC the_DT high_JJ potentiation_NN effect_NN of_IN the_DT reversal_NN of_IN resistance_NN by_IN clavulanate_NN (_( D._NP Bertei_NP et_FW al._FW ,_, Abstr_NP ._SENT 14th_JJ Reunion_NP Interdisciplin_NP ._SENT Chimiother_NP ._SENT Anti-Infect_NN ._SENT ,_, abstr_NN ._SENT 199_CD ,_, p._NN 10_CD ,_, 1994_CD )_) ._SENT Ten_CD nonduplicate_JJ strains_NNS of_IN K._NP ascorbata_NNS including_VBG the_DT type_NN strain_NN were_VBD supplied_VBN by_IN the_DT Institut_NP Pasteur_NP Collection_NP (_( Paris_NP ,_, France_NP )_) ,_, and_CC two_CD strains_NNS were_VBD isolated_VBN at_IN Tenon_NP and_CC Saint-Louis_NP Hospitals_NPS (_( Paris_NP ,_, France_NP )_) ,_, respectively_RB ._SENT Each_DT strain_NN was_VBD identified_VBN on_IN the_DT basis_NN of_IN its_PP$ behavior_NN in_IN culture_NN and_CC its_PP$ biochemical_JJ characteristics_NNS by_IN using_VBG the_DT API_NP 20E_JJ system_NN (_( bioMerieux_NP ,_, Marcy-l'Etoile_NP ,_, France_NP )_) and_CC by_IN using_VBG Biotype-100_NP carbon_NN source_NN utilization_NN strips_NNS (_( bioMerieux_NNS )_) and_CC Recognizer_NP software_NN (_( Taxolab_NP ,_, Institut_NP Pasteur_NP ,_, Paris_NP ,_, France_NP )_) ._SENT The_DT patterns_NNS of_IN susceptibility_NN to_TO antibiotics_NNS usually_RB active_JJ against_IN members_NNS of_IN the_DT family_NN Enterobacteriaceae_NNS were_VBD determined_VBN by_IN the_DT disk_NN diffusion_NN method_NN ,_, as_RB described_VBN previously_RB ._SENT The_DT MICs_NP of_IN 12_CD beta-lactams_NNS including_VBG penicillins_NNS and_CC cephalosporins_NNS in_IN the_DT presence_NN or_CC absence_NN of_IN beta-lactamase_JJ inhibitors_NNS (_( clavulanate_NN at_IN 2_CD mug/ml_NN or_CC tazobactam_NN at_IN 4_CD mug/ml_NN )_) were_VBD determined_VBN by_IN a_DT dilution_NN method_NN on_IN Mueller-Hinton_NP agar_NN (_( Sanofi_NP Diagnostics_NP Pasteur_NP ,_, Marnes_NP La_NP Coquette_NP ,_, France_NP )_) with_IN an_DT inoculum_NN of_IN 105_CD CFU/spot_NN applied_VBN with_IN a_DT multi-inoculation_NN device_NN (_( Multipoint_NP Inoculator_NP A400_NP ;_: Denleytech_NP ,_, Woking_NP ,_, United_NP Kingdom_NP )_) ._SENT All_DT strains_NNS tested_VBD a_DT low_JJ level_NN of_IN resistance_NN to_TO penicillins_NNS (_( amoxicillin_NP ,_, ticarcillin_NP ,_, piperacillin_NP )_) but_CC also_RB displayed_VBD a_DT low_JJ level_NN of_IN resistance_NN to_TO cephalothin_NN and_CC cefuroxime_NN ._SENT Significant_JJ synergy_NN with_IN clavulanate_NN was_VBD observed_VBN for_IN amoxicillin_NN and_CC ticarcillin_NN (_( 32-_CD to_TO 512-fold_NN )_) ._SENT A_DT low_JJ level_NN of_IN synergy_NN was_VBD also_RB observed_VBN between_IN piperacillin_NN and_CC tazobactam_NN ,_, which_WDT correlated_VBD with_IN the_DT high_JJ level_NN of_IN activity_NN of_IN the_DT ureidopenicillin_NN piperacillin_NN ._SENT Finally_RB ,_, all_DT strains_NNS tested_VBN were_VBD highly_RB susceptible_JJ to_TO extended-spectrum_NN cephalosporins_NNS ,_, moxalactam_NN ,_, cefoxitin_NN ,_, aztreonam_NP ,_, and_CC imipenem_NN ._SENT TABLE_NN 1_CD |_SYM MICs_NN of_IN 12_CD beta-lactams_NNS for_IN the_DT 12_CD clinical_JJ K._NP ascorbata_NN isolates_NNS ,_, recipient_JJ strain_NN E._NP coli_NNS XL-1_JJ ,_, and_CC the_DT E._NP coli_NNS XL-1_JJ transformant_NN producing_VBG KLUA-1_NP Subsequently_NP ,_, the_DT resistance_NN pattern_NN was_VBD correlated_VBN with_IN beta-lactamase_NN production_NN ._SENT The_DT beta-lactamase_NN contents_NNS were_VBD obtained_VBN from_IN sonicated_NN extracts_VBZ of_IN bacteria_NNS cultured_VBN overnight_RB at_IN 37C_JJ in_IN Trypticase_NP soy_NN broth_NN (_( bioMerieux_NNS )_) ,_, prepared_VBN as_IN described_VBN previously_RB ._SENT Analytical_NP isoelectric_JJ focusing_VBG (_( IEF_NP )_) was_VBD performed_VBN in_IN a_DT polyacrylamide_NN gel_NN as_RB described_VBD previously_RB by_IN the_DT iodiometric_JJ procedure_NN with_IN benzylpenicillin_NN for_IN detection_NN ._SENT We_PP detected_VBD beta-lactamases_NNS with_IN different_JJ pIs_NNS ,_, as_RB follows_VBZ :_: pI_NP 6.9_CD ,_, two_CD strains_NNS ;_: pI_NP 8.0_CD ,_, six_CD strains_NNS ;_: pI_NP 8.4_CD ,_, four_CD strains_NNS (_( see_VB Table_NP )_) ._SENT Finally_RB ,_, the_DT substrate_NN and_CC inhibition_NN profiles_NNS of_IN a_DT single_JJ crude_NN extract_NN (_( type_NN strain_NN CIP_NP 82.95T_NP )_) were_VBD determined_VBN ._SENT This_DT extract_NN was_VBD produced_VBN from_IN 4_CD liters_NNS of_IN culture_NN grown_VBN in_IN brain_NN heart_NN infusion_NN (_( Difco_NP ,_, Detroit_NP ,_, Mich._NP )_) and_CC incubated_VBN at_IN 37C_JJ for_IN 5_CD h_NN after_IN initial_JJ inoculation_NN of_IN 300_CD ml_NN of_IN a_DT starter_JJ culture_NN ._SENT Cells_NNS were_VBD harvested_VBN by_IN centrifugation_NN at_IN 5,800_CD x_NN g_NN for_IN 30_CD min_NN at_IN 4C_JJ ._SENT The_DT pellets_NNS (_( about_RB 20_CD g_NN )_) were_VBD washed_VBN by_IN resuspension_NN in_IN 40_CD ml_NN of_IN ice-cold_JJ 0.1_CD M_NP NaCl_NP plus_CC 0.05_CD M_NP sodium_NN azide_NN and_CC centrifuged_VBD as_RB described_VBN above_IN ._SENT The_DT washed_JJ pellet_NN was_VBD resuspended_VBN in_IN 40_CD ml_NN of_IN the_DT same_JJ solution_NN and_CC lysed_VBN by_IN ultrasound_NN treatment_NN (_( three_CD times_NNS for_IN 10_CD s_NNS each_DT time_NN per_IN gram_NN of_IN pellets_NNS ;_: power_NN =_SYM 50_CD W_NN and_CC frequency_NN =_SYM 20_CD kHz_NN with_IN type_NN 20-200_CD equipment_NN [_SYM Alcatel_NP ,_, Paris_NP ,_, France_NP ]_SYM )_) ._SENT The_DT crude_JJ extract_NN was_VBD cleared_VBN by_IN centrifugation_NN at_IN 48,000_CD x_NN g_NN for_IN 30_CD min_NN at_IN 4C_JJ ._SENT Nucleic_JJ acids_NNS were_VBD precipitated_VBN by_IN adding_VBG 0.2_CD M_NN spermine_NN (_( Sigma_NP ,_, Saint-Quentin_NP Fallavier_NP ,_, France_NP )_) and_CC centrifugation_NN (_( 48,000_CD x_SYM g_NN for_IN 30_CD min_NN at_IN 4C_JJ )_) ._SENT The_DT crude_JJ extract_NN was_VBD then_RB subjected_VBN to_TO chromatography_NN on_IN a_DT Sephadex_NP G100_NP column_NN ._SENT The_DT active_JJ fractions_NNS were_VBD pooled_VBN ,_, subjected_VBN to_TO chromatography_NN on_IN Bio-Rex_NP 70_CD resin_NN ,_, and_CC then_RB concentrated_VBN by_IN ultrafiltration_NN ._SENT The_DT kinetic_JJ constants_NNS Vmax_NP ,_, which_WDT was_VBD expressed_VBN relative_JJ to_TO the_DT Vmax_NP for_IN benzylpenicillin_NN (_( which_WDT was_VBD set_VBN at_IN 100_CD %_NN )_) ,_, and_CC Km_NP were_VBD determined_VBN by_IN computerized_JJ microacidimetric_JJ assay_NN in_IN 0.1_CD M_NP NaCl_NP at_IN pH_NN 7.0_CD and_CC 37C_JJ ._SENT One_CD unit_NN of_IN beta-lactamase_NN was_VBD defined_VBN as_IN the_DT amount_NN of_IN enzyme_NN that_WDT hydrolyzed_VBD 1_CD mumol_NN of_IN benzylpenicillin_NN per_IN min_NN at_IN pH_NN 7.0_CD and_CC 37C_JJ ._SENT Kinetic_JJ analysis_NN showed_VBD that_IN the_DT activity_NN of_IN the_DT enzyme_NN was_VBD highest_RBS with_IN cephalothin_NN ,_, but_CC that_DT cefuroxime_NN and_CC cefotaxime_NN were_VBD also_RB good_JJ substrates_NNS ._SENT Conversely_RB ,_, the_DT enzyme_NN displayed_VBD a_DT low_JJ level_NN of_IN activity_NN with_IN ceftazidime_NN ,_, aztreonam_NP ,_, and_CC cephamycin_NN ._SENT Tazobactam_NP was_VBD the_DT most_RBS efficient_JJ inhibitor_NN (_( 50_CD %_NN inhibitory_JJ concentration_NN [_SYM IC50_NP ]_SYM ,_, 10_CD nM_NN )_) ,_, closely_RB followed_VBN by_IN clavulanic_JJ acid_NN (_( IC50_NP ,_, 20_CD nM_NN )_) ._SENT Sulbactam_NP was_VBD the_DT least_JJS potent_JJ inhibitor_NN (_( IC50_NP ,_, 100_CD nM_NN )_) ._SENT Finally_RB ,_, chloride_NN ions_NNS at_IN a_DT concentration_NN of_IN 0.5_CD M_NP had_VBD no_DT inhibitory_JJ effect_NN ._SENT TABLE_NN 3_CD |_SYM Genotypic_JJ characterization_NN of_IN beta-lactamase_NN contents_NNS of_IN K._NP ascorbata_NN strains_NNS and_CC beta-lactamase_NN pIs_NN TABLE_NP 2_CD |_SYM Kinetic_JJ constants_NNS (_( Vmax_NP ,_, Km_NP )_) of_IN beta-lactamase_NN produced_VBN by_IN K._NP ascorbata_NNS strain_VBP CIP_NP 82_CD ._SENT 95T_NN The_DT identification_NN of_IN only_RB one_CD susceptibility_NN pattern_NN among_IN the_DT 12_CD strains_NNS of_IN K._NP ascorbata_NNS tested_VBN suggested_VBD that_IN this_DT species_NN possesses_VBZ a_DT naturally_RB occurring_VBG ,_, chromosomally_RB mediated_VBN beta-lactamase_NN ._SENT Furthermore_RB ,_, this_DT assumption_NN was_VBD confirmed_VBN by_IN the_DT failure_NN of_IN both_DT conjugation_NN experiments_NNS and_CC plasmid_NN extraction_NN with_IN the_DT High_NP Pure_NP plasmid_NP isolation_NN kit_NN (_( Roche_NP Biochemicals_NP ,_, Neuilly-sur-Seine_NP ,_, France_NP )_) ._SENT On_IN the_DT basis_NN of_IN the_DT observed_JJ pattern_NN of_IN susceptibility_NN and_CC enzymatic_JJ properties_NNS ,_, we_PP designed_VBD degenerate_JJ oligonucleotide_NN primers_NNS from_IN the_DT sequences_NNS of_IN genes_NNS encoding_VBG CTX-M-type_NP enzymes_NNS (_( primer_JJR MA1-forward_NP [_SYM 5'-SCSATGTGCAGYACCAGTAA-3_JJ '_'' ]_SYM and_CC primer_JJR MA2-reverse_NP [_SYM 5'-CCGCRATATGRTTGGTGGTG-3_JJ '_'' ]_SYM )_) and_CC used_VBD them_PP to_TO amplify_VB an_DT internal_JJ fragment_NN of_IN the_DT K._NP ascorbata_NN bla_NN genes_NNS ._SENT In_IN each_DT PCR_NP ,_, the_DT cycling_NN conditions_NNS were_VBD as_RB follows_VBZ :_: 35_CD cycles_NNS of_IN 60_CD s_NNS at_IN 94C_NN for_IN denaturation_NN ,_, 30_CD s_NNS at_IN 60C_JJ for_IN annealing_VBG ,_, and_CC 30_CD s_NNS at_IN 72C_NP for_IN elongation_NN with_IN 2_CD U_NN of_IN Taq_NP DNA_NP polymerase_NN (_( Perkin-Elmer_NP ,_, Foster_NP City_NP ,_, Calif._NP )_) ._SENT Amplifications_NNS were_VBD obtained_VBN for_IN all_DT K._NP ascorbata_NN strains_NNS producing_VBG a_DT beta-lactamase_NN of_IN pI_NP 8.0_CD or_CC 8.4_CD ._SENT Nevertheless_RB ,_, the_DT two_CD bla_NN genes_NNS encoding_VBG beta-lactamase_NN of_IN pI_NP 6.9_CD were_VBD not_RB amplified_VBN with_IN these_DT CTX-M-specific_JJ primers_NNS ._SENT The_DT PCR_NP products_NNS were_VBD then_RB purified_VBN with_IN Qiagen_NP (_( Courtaboeuf_NP ,_, France_NP )_) columns_NNS ,_, and_CC the_DT DNA_NP sequences_NNS were_VBD determined_VBN twice_RB on_IN both_DT strands_NNS by_IN the_DT procedure_NN of_IN Sanger_NP et_FW al._FW by_IN using_VBG fluorescent_JJ dye-labeled_JJ dideoxynucleotides_NNS ,_, thermal_JJ cycling_NN with_IN Taq_NP polymerase_NN ,_, and_CC an_DT ABI_NP 373A_NP DNA_NP sequencer_NN (_( Applied_NP Biosystems_NP ,_, Foster_NP City_NP ,_, Calif._NP )_) ._SENT All_DT PCR_NP products_NNS consisted_VBD of_IN a_DT 540-bp_JJ fragment_NN ,_, which_WDT was_VBD found_VBN to_TO be_VB highly_RB similar_JJ (_( >97_JJ %_NN identity_NN )_) to_TO the_DT cluster_NN that_WDT included_VBD the_DT blaCTX-M-2_NN ,_, blaCTX-M-4_JJ ,_, blaCTX-M-5_JJ ,_, blaCTX-M-6_JJ ,_, blaCTX-M-7_JJ ,_, and_CC blaToho-1_JJ genes_NNS ._SENT Finally_RB ,_, other_JJ primers_NNS more_RBR specific_JJ for_IN the_DT blaCTX-M_NN gene_NN of_IN this_DT cluster_NN were_VBD used_VBN to_TO amplify_VB the_DT entire_JJ Kluyvera_NP bla_NN gene_NN :_: primers_NNS M3-forward_NP (_( 5'-ATGATGACTCAGAGCATTCGC-3_NP '_POS )_) and_CC M3-reverse_NP (_( 5'-GGGCAATCAGCTTATTCATGG-3_NP '_POS )_) and_CC primers_NNS M4-forward_NP (_( 5'-TTGCTCGCTCGTTGGGTGAT-3_NP '_POS )_) and_CC M4-reverse_NP (_( 5'-TATTGCATCAGAAACCGTGGG-3_NP '_POS )_) ._SENT Amplifications_NNS with_IN primer_NN M3_NP or_CC M4_NP were_VBD performed_VBN by_IN using_VBG the_DT same_JJ cycling_NN conditions_NNS described_VBD above_IN ._SENT The_DT nucleotide_NN sequences_NNS of_IN K._NP ascorbata_NN genes_NNS encoding_VBG a_DT beta-lactamase_NN with_IN a_DT pI_NN of_IN 8.0_CD or_CC 8.4_CD (_( blaKLUA-1_NN to_TO blaKLUA-5_NN and_CC blaKLUA-8_NN to_TO blaKLUA-12_NN )_) were_VBD determined_VBN ._SENT High_JJ degrees_NNS of_IN homology_NN (_( >95_JJ %_NN )_) were_VBD observed_VBN among_IN all_PDT these_DT blaKLUA_NN genes_NNS coding_VBG for_IN class_NN A_DT beta-lactamases_NNS ._SENT Moreover_RB ,_, blaKLUA_NN genes_NNS were_VBD also_RB found_VBN to_TO share_VB extensive_JJ similarities_NNS (_( 95_CD to_TO 100_CD %_NN )_) with_IN the_DT genes_NNS producing_VBG the_DT CTX-M-2_NP ,_, CTX-M-4_NP ,_, CTX-M-5_NP ,_, CTX-M-6_NP ,_, CTX-M-7_JJ ,_, and_CC Toho-1_JJ beta-lactamases_NNS ;_: but_CC they_PP displayed_VBD lower_JJR levels_NNS of_IN identity_NN with_IN the_DT genes_NNS for_IN the_DT other_JJ CTX-M_NP types_NNS (_( 68_CD to_TO 84_CD %_NN )_) ._SENT However_RB ,_, this_DT high_JJ level_NN of_IN similarity_NN observed_VBN suggested_VBD that_IN the_DT chromosome-encoded_JJ beta-lactamase_NN of_IN K._NP ascorbata_NNS is_VBZ a_DT more_RBR probable_JJ progenitor_NN of_IN at_IN least_JJS some_DT plasmid-encoded_JJ CTX-M_NP enzymes_NNS than_IN K._NP oxytoca_NP ._SENT Finally_RB ,_, the_DT highest_JJS degrees_NNS of_IN homology_NN between_IN blaKLUA_NN and_CC chromosome-encoded_JJ bla_NN genes_NNS were_VBD observed_VBN for_IN class_NN A_DT enzymes_NNS produced_VBN by_IN Kluyvera_NP cryocrescens_NNS (_( ~77_JJ %_NN )_) ,_, S._NP fonticola_NP (_( ~74_NN %_NN )_) ,_, K._NP oxytoca_NP (_( ~73_NN %_NN )_) ,_, and_CC Citrobacter_NP sedlakii_NP (_( ~73_NN %_NN )_) (_( ,_, ,_, ;_: C._NP Humeniuk_NP ,_, unpublished_JJ data_NNS )_) ._SENT Only_RB two_CD bla_NN genes_NNS encoding_VBG a_DT beta-lactamase_NN of_IN pI_NP 6.9_CD were_VBD not_RB amplified_VBN with_IN the_DT CTX-M-specific_JJ primers_NNS ._SENT Characterization_NN of_IN a_DT beta-lactamase(s)_NN produced_VBN by_IN both_DT of_IN these_DT strains_NNS is_VBZ in_IN progress_NN ._SENT In_IN fact_NN ,_, it_PP appears_VBZ that_IN K._NP ascorbata_NNS could_MD produce_VB at_IN least_JJS two_CD different_JJ kinds_NNS of_IN beta-lactamase_NN genes_NNS ,_, as_RB has_VBZ been_VBN observed_VBN for_IN K._NP oxytoca_NP ,_, in_IN which_WDT two_CD main_JJ groups_NNS of_IN beta-lactamase_NN genes_NNS have_VBP been_VBN distinguished_VBN (_( blaOXY-1_JJ and_CC blaOXY-2_JJ ;_: identity_NN ,_, 90_CD %_NN )_) ._SENT This_DT heterogeneity_NN of_IN the_DT K._NP ascorbata_NN beta-lactamases_NNS could_MD be_VB correlated_VBN with_IN the_DT diversity_NN observed_VBD among_IN CTX-M-type_NP enzymes_NNS ,_, which_WDT are_VBP divided_VBN into_IN five_CD clusters_NNS ._SENT TABLE_NN 4_CD |_SYM Identities_NNS of_IN amino_NN acid_NN sequences_NNS of_IN K._NP ascorbata_NN beta-lactamases_NNS and_CC CTX-M_NP ,_, Toho_NP ,_, UOE_NP beta-lactamases_NNS 1_CD ._SENT :_: As_IN the_DT chromosomal_JJ beta-lactamase_NN genes_NNS of_IN K._NP ascorbata_NNS are_VBP the_DT probable_JJ progenitors_NNS of_IN some_DT of_IN the_DT plasmid-encoded_JJ extended-spectrum_NN CTX-M-type_NN enzymes_NNS ,_, we_PP investigated_VBD the_DT genetic_JJ organization_NN of_IN blaKLUA-1_NN by_IN cloning_VBG and_CC sequencing_VBG the_DT surrounding_VBG regions_NNS of_IN this_DT gene_NN ._SENT Chromosomal_JJ DNA_NN was_VBD prepared_VBN from_IN K._NP ascorbata_NP CIP_NP 82.95T_NP ,_, partially_RB digested_VBN with_IN Sau3A_NP ,_, and_CC ligated_VBD into_IN the_DT BamHI_NP site_NN of_IN pBK-CMV_NP (_( pBK_NP Phagemid_NP Vectors_NP ;_: Stratagene_NP ,_, La_NP Jolla_NP ,_, Calif._NP )_) ,_, as_RB described_VBN previously_RB ._SENT The_DT recombinant_JJ plasmid_NN was_VBD introduced_VBN into_IN Escherichia_NP coli_NNS XL-1_JJ by_IN the_DT standard_JJ CaCl2_NP procedure_NN ._SENT Several_JJ transformants_NNS were_VBD selected_VBN on_IN Mueller-Hinton_NP agar_NN (_( Sanofi_NP Diagnostics_NP Pasteur_NP )_) supplemented_VBD with_IN amoxicillin_NN (_( 40_CD mug_NN ml-1_NN )_) and_CC kanamycin_NN (_( 25_CD mug_NN ml-1_NN )_) and_CC were_VBD further_RBR characterized_VBN by_IN determination_NN of_IN their_PP$ antibiotic_JJ susceptibility_NN profiles_NNS and_CC pIs_NNS ._SENT The_DT molecular_JJ sizes_NNS of_IN the_DT inserts_NNS were_VBD estimated_VBN from_IN the_DT results_NNS of_IN restriction_NN digestion_NN and_CC electrophoresis_NN in_IN 1_CD to_TO 3_CD %_NN agarose_NN gels_NNS ,_, as_RB described_VBN previously_RB ._SENT Finally_RB ,_, both_DT strands_NNS of_IN the_DT DNA_NP sequence_NN of_IN a_DT 7-kb_NP insert_NN were_VBD determined_VBN ._SENT The_DT BLASTN_NP program_NN on_IN the_DT National_NP Center_NP for_IN Biotechnology_NP Information_NP website_NN (_( revision_NN date_NN ,_, 20_CD July_NP 2001_CD ;_: )_) was_VBD used_VBN for_IN database_NN searches_NNS ._SENT Three_CD open_JJ reading_NN frames_NNS (_( ORFs_NP )_) were_VBD found_VBN immediately_RB upstream_JJ (_( 2,980_CD bp_NN )_) and_CC downstream_JJ (_( 3,300_CD bp_NN )_) of_IN the_DT blaKLUA_NN gene_NN (_( ORF_NP 2_CD )_) ._SENT The_DT protein_NN corresponding_JJ to_TO ORF_NP 1_CD was_VBD 86_CD %_NN identical_JJ to_TO an_DT aspartate_JJ aminotransferase_NN from_IN E._NP coli_NNS ._SENT The_DT deduced_VBN amino_NN acid_NN sequence_NN of_IN the_DT protein_NN encoded_VBN by_IN ORF_NP 3_CD was_VBD 43_CD %_NN identical_JJ to_TO that_DT of_IN a_DT putative_JJ protein_NN from_IN E._NP coli_NNS ._SENT The_DT protein_NN encoded_VBN by_IN the_DT fourth_JJ ORF_NP showed_VBD various_JJ degrees_NNS of_IN similarity_NN (_( 28_CD to_TO 56_CD %_NN )_) to_TO adhesive_JJ proteins_NNS (_( MisL_NP ,_, AidaI_NP ,_, VirG_NP )_) known_VBN to_TO contribute_VB to_TO the_DT pathogenicities_NNS of_IN several_JJ enterobacteria_NNS ._SENT Recently_RB ,_, the_DT nucleotide_NN sequence_NN of_IN blaKLUC_NN ,_, which_WDT encodes_VBZ the_DT chromosomal_JJ beta-lactamase_NN of_IN K._NP cryocrescens_NNS ,_, and_CC its_PP$ surrounding_VBG regions_NNS has_VBZ been_VBN reported_VBN ._SENT Genes_NNS corresponding_JJ to_TO an_DT aspartate_JJ aminotransferase_NN and_CC a_DT putative_JJ protein_NN showing_VBG 94_CD and_CC 66_CD %_NN identities_NNS with_IN the_DT proteins_NNS encoding_VBG by_IN K._NP ascorbata_NN ORF_NP 1_CD and_CC ORF_NP 3_CD ,_, respectively_RB ,_, were_VBD found_VBN upstream_RB and_CC downstream_RB of_IN the_DT blaKLUC_NN gene_NN ._SENT In_IN fact_NN ,_, this_DT particular_JJ genetic_JJ organization_NN could_MD be_VB a_DT characteristic_NN of_IN the_DT genus_NN Kluyvera_NP ._SENT Finally_RB ,_, no_DT ampR_NN gene_NN was_VBD detected_VBN upstream_RB of_IN the_DT blaKLUA-1_JJ gene_NN ._SENT Indeed_RB ,_, some_DT class_NN A_DT beta-lactamases_NNS closely_RB related_VBN to_TO K._NP ascorbata_NN enzymes_NNS are_VBP regulated_VBN by_IN an_DT ampR_NN gene_NN :_: cumR_NP (_( Proteus_NP vulgaris_NP )_) ,_, sedR_NP (_( C._NP sedlakii_NP )_) ,_, and_CC fonR_NP (_( S._NP fonticola_NP )_) (_( C._NP Humeniuk_NP ,_, unpublished_JJ data_NNS )_) ._SENT FIG._NN 1_CD ._SENT |_SYM Genetic_JJ environment_NN of_IN blaKLUA-1_JJ gene_NN encoding_VBG the_DT beta-lactamase_NN produced_VBN by_IN K._NP ascorbata_NNS Genetic_JJ environment_NN of_IN blaKLUA-1_JJ gene_NN encoding_VBG the_DT beta-lactamase_NN produced_VBN by_IN K._NP ascorbata_NNS strain_VBP CIP_NP 82.95T_NP ._SENT The_DT regions_NNS surrounding_VBG the_DT chromosomal_JJ blaKLUA-1_JJ gene_NN and_CC the_DT sequences_NNS adjacent_JJ to_TO the_DT plasmidic_JJ genes_NNS encoding_VBG beta-lactamases_NNS CTX-M-2_NP ,_, CTX-M-4_NP ,_, CTX-M-5_NP ,_, CTX-M-6_NP ,_, CTX-M-7_JJ ,_, and_CC Toho-1_NP were_VBD compared_VBN ._SENT The_DT RTR_NP sequence_NN and_CC tnpA_NN correspond_VBP to_TO the_DT right_JJ terminal_NN repeat_NN and_CC transposase_NN A_NP ,_, respectively_RB ,_, which_WDT are_VBP typical_JJ of_IN ISEcp1_NP ._SENT The_DT analysis_NN of_IN the_DT sequences_NNS surrounding_VBG the_DT blaCTX-M_NN genes_NNS revealed_VBD the_DT presence_NN of_IN sequences_NNS similar_JJ to_TO those_DT for_IN CTX-M-5_NP on_IN the_DT K._NP ascorbata_NN chromosome_NN (_( 5_CD nucleotides_NNS [_SYM nt_NNS ]_SYM upstream_JJ and_CC 179_CD nt_NNS downstream_JJ with_IN 80_CD and_CC 100_CD %_NN identities_NNS ,_, respectively_RB ,_, with_IN the_DT chromosome_NN of_IN K._NP ascorbata_NNS )_) ,_, Toho-1_NP (_( 49_CD nt_NNS upstream_RB and_CC 71_CD nt_NNS downstream_JJ with_IN 95.9_CD and_CC 98.6_CD %_NN identities_NNS ,_, respectively_RB )_) ,_, and_CC CTX-M-2_NP ,_, -M-4_NP ,_, -M-6_NN ,_, and_CC -M-7_JJ (_( 29_CD nt_NNS upstream_RB with_IN 100_CD %_NN identity_NN )_) ._SENT However_RB ,_, major_JJ differences_NNS between_IN the_DT adjacent_JJ sequences_NNS of_IN the_DT other_JJ blaCTX-M_NN genes_NNS (_( CTX-M-1_NP ,_, -M-3_NN ,_, -M-8_JJ ,_, -M-12_JJ ,_, -M-13_JJ ,_, -M-14_JJ ,_, and_CC -M-15_NN ;_: Toho-2_NP ;_: UOE-1_NP ;_: and_CC UOE-2_NP )_) and_CC the_DT chromosome_NN of_IN K._NP ascorbata_NNS were_VBD observed_VBN ._SENT This_DT fact_NN confirms_VBZ that_IN the_DT beta-lactamase_NN of_IN K._NP ascorbata_NNS is_VBZ probably_RB the_DT progenitor_NN of_IN only_RB some_DT plasmid-encoded_JJ CTX-M-type_NP enzymes_NNS ._SENT To_TO date_NN ,_, this_DT is_VBZ the_DT second_JJ report_NN of_IN the_DT mobilization_NN of_IN a_DT chromosomally_RB mediated_VBN class_NN A_DT beta-lactamase_NN ._SENT So_RB far_RB we_PP have_VBP investigated_VBN the_DT potential_JJ mechanism_NN of_IN mobilization_NN of_IN the_DT blaKLUA_NN gene_NN by_IN sequencing_VBG surrounding_VBG regions_NNS of_IN the_DT blaCTX-M-5_JJ gene_NN located_VBN on_IN plasmid_NN pCLL3417_JJ ._SENT The_DT GenBank_NP accession_NN number_NN for_IN this_DT nucleotide_NN sequence_NN is_VBZ ._SENT Sequencing_NP confirmed_VBD the_DT presence_NN of_IN sequences_NNS similar_JJ to_TO that_DT of_IN the_DT K._NP ascorbata_NN chromosome_NN (_( 19_CD nt_NNS upstream_RB and_CC 256_CD nt_NNS downstream_JJ with_IN 85_CD and_CC 98.6_CD %_NN identities_NNS ,_, respectively_RB )_) and_CC revealed_VBD the_DT presence_NN of_IN the_DT novel_JJ insertion_NN sequence_NN ,_, ISEcp1_NP ,_, described_VBN by_IN Stapleton_NP (_( P._NP D._NP Stapleton_NP ,_, Abstr_NP ._SENT 39th_JJ Intersci_NP ._SENT Conf_NP ._SENT Antimicrob_NN ._SENT Agents_NPS Chemother_NP ._SENT ,_, abstr_NN ._SENT 1457_CD ,_, 1999_CD )_) ._SENT Subsequently_RB ,_, this_DT element_NN was_VBD reported_VBN for_IN several_JJ plasmid-encoded_JJ AmpC_NP enzymes_NNS including_VBG CMY-5_NP ,_, LAT-1_NP ,_, and_CC ACC-1_NP ,_, which_WDT were_VBD probably_RB mobilized_VBN from_IN chromosomal_JJ beta-lactamases_NNS of_IN C._NP freundii_NP or_CC H._NP alvei_NP ._SENT It_PP was_VBD also_RB detected_VBN on_IN plasmids_NNS carrying_VBG other_JJ blaCTX-M_NN genes_NNS (_( CTX-M-3-like_NP ,_, CTX-M-14_NP ,_, CTX-M-15_NP ,_, Toho-1_NP ,_, Toho-2_NP ,_, and_CC UOE-2_NP )_) (_( ,_, ,_, ;_: GenBank_NP accession_NN numbers_NNS ,_, ,_, and_CC )_) ._SENT Given_VBN the_DT low_JJ level_NN of_IN clinical_JJ importance_NN of_IN K._NP ascorbata_NNS ,_, it_PP is_VBZ important_JJ to_TO consider_VB the_DT possible_JJ transfer_NN of_IN the_DT bla_NN gene_NN in_IN veterinary_JJ practice_NN or_CC in_IN the_DT environment_NN ._SENT Several_JJ preliminary_JJ reports_NNS have_VBP indeed_RB described_VBN Salmonella_NP enterica_NP serovar_NN Typhimurium_NN as_IN producing_VBG beta-lactamases_NNS of_IN the_DT CTX-M2_NP ,_, CTX-M-4_NP ,_, CTX-M-5_NP ,_, and_CC CTX-M-7_JJ types_NNS in_IN various_JJ countries_NNS (_( Argentina_NP ,_, Latvia_NP ,_, Russia_NP ,_, Greece_NP )_) ._SENT If_IN K._NP ascorbata_NN acts_NNS as_IN a_DT reservoir_NN for_IN these_DT plasmid-encoded_JJ CTX-M_NP enzymes_NNS ,_, the_DT sequences_NNS of_IN more_JJR chromosomal_JJ genes_NNS must_MD be_VB determined_VBN to_TO confirm_VB the_DT existence_NN of_IN a_DT single_JJ progenitor_NN due_JJ to_TO the_DT heterogeneity_NN observed_VBD in_IN the_DT CTX-M_NP cluster_NN ._SENT The_DT GenBank_NP accession_NN number_NN for_IN the_DT nucleotide_NN sequence_NN of_IN the_DT insert_NN reported_VBD in_IN this_DT paper_NN is_VBZ ._SENT 